Partial cystectomy with adjuvant chemotherapy or radiation therapy for muscle invasive bladder cancer (literature review)


  • B.M. Navrotskyi Bogomolets National Medical University, Kyiv, Ukraine,



trimodal bladder cancer therapy, muscle invasive bladder cancer, partial cystectomy, radical cystectomy


Cisplatin-based neoadjuvant chemotherapy followed by radical cystectomy is considered the gold standard for the treatment of muscle invasive bladder cancer, given the large number of randomized controlled trials. At all stages of the tumor, this approach has been associated with the highest survival rates. However, radical cystectomy is one of the most difficult procedures performed by urologists, it is associated with a significant risk of complications in the postoperative period and even with a low risk of death, and in many cases — with a significant decrease in the quality of life of patients.


Smelser W.W., Austenfeld M.A. et al. Where are we with bladder preservation for muscle-invasive bladder cancer in 2017? Indian Journal of Urology. 2017. 33(2). 111-117.

I-Hung Shao, Ying Hsu Chang. Outcomes and prognostic factors of simple partial cystectomy for localized bladder urothelial cell carcinoma. Wiley Online Library. 2016. 32(4). 191-195.

Jasen Abel E. et al. Partial Cystectomy. MedScape Overview (Upd. 2019).

Knoedler J., Frank I. Organ-sparing surgery in urology: partial cystectomy. Curr. Opin. Urol. 2015. 25. 111-115.

Knoedler J. et al. Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis. J. Urol. 2012. 188(4). 1115-1119

Tai H.C., Chung S.D., Wang S.M., Chueh S.C., Yu H.J. La­paroscopic partial cystectomy for various bladder pathologies. BJU Int. 2007. 100. 382-385.

Fedeli U., Fedewa S.A., Ward E.M. Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007. J. Urol. 2011. 185(1). 72-78.

Herr H.W. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy. Eur. Urol. 2009. 55(4). 920-921.

Ploussard G. Critical Analysis of Bladder Sparing with Trimo­dal Therapy in Muscle-invasive Bladder Cancer: A Syste­matic Review. European Urology. 2014. 66. 120-137.

James N. et al. Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer. N. Engl. J. Med. 2012. 366.


Pos J.F. Adaptive radiotherapy for invasive bladder cancer. N. Engl. J. Med. 2010. 344. 1211-5.



Young Scientist